Markets:

Overview

News

Currencies

International

Treasuries

McKesson Corp (NY:MCK)

949.05 +1.57 (+0.17%)

Streaming Delayed Price Updated: 3:11 PM EST, Feb 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about McKesson Corp

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

3 Market-Beating Stocks for Long-Term Investors

February 19, 2026

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends...

Via StockStory

Topics Supply Chain

2 Surging Stocks to Own for Decades and 1 We Find Risky

February 16, 2026

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

2 Momentum Stocks Worth Your Attention and 1 We Ignore

February 15, 2026

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

Via StockStory

5 Insightful Analyst Questions From McKesson’s Q4 Earnings Call

February 11, 2026

McKesson’s fourth-quarter results met Wall Street’s revenue expectations and modestly exceeded consensus for non-GAAP earnings per share, with the market responding positively. Management attributed...

Via StockStory

Topics Artificial Intelligence Earnings

McKesson Corp (NYSE:MCK) Reports Mixed Q3 2026 Results and Raises Full-Year Profit Outlook ↗

February 04, 2026

Via Chartmill

McKesson (MCK): A Structural Re-rating Driven by Oncology and GLP-1 Momentum

February 06, 2026

McKesson Corporation (NYSE: MCK) stands today as the undisputed titan of the U.S. pharmaceutical supply chain. While the company has long been a staple of the Fortune 500, its relevance has surged in...

Via Finterra

Topics Artificial Intelligence Economy Fraud

Thursday's session: top gainers and losers in the S&P500 index ↗

February 05, 2026

Via Chartmill

How the Largest IPO of 2025 Could Be Healthy for Your Portfolio ↗

February 05, 2026

Medline is an appealing investment candidate – it has solid growth, operates in a steady industry, and a storied history.

Via The Motley Fool

Topics Economy Initial Public Offering

MCK Q4 Deep Dive: Oncology, Tech Investments, and Portfolio Focus Drive Growth

February 05, 2026

Healthcare distributor and services company McKesson (NYSE:MCK) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.4% year on year to $106.2 billion. Its non-GAAP profit of $9.34 per...

Via StockStory

McKesson Corp (NYSE:MCK) Fits the 'Affordable Growth' Investment Profile ↗

January 29, 2026

Via Chartmill

McKesson Corp (NYSE:MCK) Demonstrates Strong Growth and Technical Breakout Potential ↗

January 20, 2026

Via Chartmill

McKesson (MCK) Q3 2026 Earnings Call Transcript ↗

February 04, 2026

McKesson (MCK) Q3 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

McKesson (NYSE:MCK) Reports Q4 CY2025 In Line With Expectations

February 04, 2026

Via StockStory

McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance

February 04, 2026

From McKesson Corporation

Via Business Wire

Earnings To Watch: McKesson (MCK) Reports Q4 Results Tomorrow

February 02, 2026

Healthcare distributor and services company McKesson (NYSE:MCK) will be announcing earnings results this Wednesday after the bell. Here’s what to expect.

Via StockStory

McKesson Corporation Completes Divestiture of Norwegian Operations

January 30, 2026

From McKesson Corporation

Via Business Wire

McKesson Corporation Declares Quarterly Dividend

January 28, 2026

From McKesson Corporation

Via Business Wire

One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan ↗

December 29, 2025

An improving earnings profile, aggressive buybacks, and a renewed focus on margins might be changing how long-term investors think about this healthcare distributor.

Via The Motley Fool

Topics Regulatory Compliance

McKesson Corp (NYSE:MCK): A GARP Stock with Strong Growth at a Reasonable Price ↗

December 26, 2025

McKesson Corp exemplifies GARP investing, offering strong earnings growth at a reasonable valuation within the vital healthcare supply chain.

Via Chartmill

1 Large-Cap Stock with Impressive Fundamentals and 2 Facing Challenges

December 23, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Via StockStory

3 Big Reasons to Love McKesson (MCK)

December 23, 2025

McKesson trades at $825.38 and has moved in lockstep with the market. Its shares have returned 14.5% over the last six months while the S&P 500 has gained 12.9%.

Via StockStory

Topics Stocks Supply Chain

Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR

December 23, 2025

CRANFORD, NJ — As the 2025 calendar year draws to a close, Citius Oncology, Inc. (Nasdaq: CTOR) has reached a pivotal juncture in its corporate evolution. Following the release of its SEC 10-K filing...

Via MarketMinute

Topics Economy Regulatory Compliance

Mckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release Date

December 22, 2025

From McKesson Corporation

Via Business Wire

Medline’s Blockbuster IPO Ignites Market Optimism: The Largest Debut Since 2021

December 18, 2025

In a stunning return to the public stage, Medline Industries (Nasdaq: MDLN) successfully executed the largest initial public offering (IPO) in the United States since 2021, pricing its shares at the...

Via MarketMinute

Topics Economy Initial Public Offering World Trade

Medline Industries (MDLN) Deep-Dive: The $54 Billion Return of a Healthcare Titan

December 18, 2025

The global healthcare landscape shifted decisively on December 16, 2025, with the public market return of Medline Industries (Nasdaq: MDLN). After four years under the stewardship of a private equity...

Via PredictStreet

Topics Artificial Intelligence Earnings Economy

McKesson Corp (NYSE:MCK) Presents a Compelling Growth and Technical Breakout Setup ↗

December 17, 2025

McKesson Corp combines strong earnings growth with a bullish technical setup, offering a potential entry point in the healthcare sector.

Via Chartmill

2 S&P 500 Stocks with Competitive Advantages and 1 We Question

December 11, 2025

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...

Via StockStory

Topics Stocks

2 Growth Stocks to Add to Your Roster and 1 We Avoid

December 09, 2025

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Via StockStory

Topics Economy

1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off

December 07, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the...

Via StockStory

Topics Stocks

Which S&P500 stocks are moving on Wednesday? ↗

December 03, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.